Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia

被引：63

作者：

Tsai, SJ

Wang, YC

Hong, CJ

机构：

[1] Vet Gen Hosp, Dept Psychiat, Taipei 11217, Taiwan

[2] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei 112, Taiwan

[3] Yu Li Vet Hosp, Sect Psychiat, Hualien, Taiwan

来源：

PSYCHIATRIC GENETICS | 2000年 / 10卷 / 03期

关键词：

association study; cannabinoid receptor 1; genetics; polymorphism; schizophrenia;

D O I：

10.1097/00041444-200010030-00008

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Cannabis can induce schizophrenic-like symptoms in healthy individuals. A principal active ingredient of cannabis, delta-9-tetrahydrocannabinol, acts in the brain on a specific receptor, termed the cannabinoid receptor 1 (CNR1). The human gene for CNR1 is mapped to chromosome 6q14-15, and linkage studies have produced evidence for a schizophrenia-susceptibility locus in this region. To explore a possible role for CNR1 in the pathogenesis of schizophrenic disorders, we used an association study to genotype the CNR1 polymorphism for 127 schizophrenic patients and 146 control subjects. The results demonstrate no association between CNR1 genotypes and schizophrenic disorders (P = 0.409), with these negative findings suggesting that, for Chinese populations, the (AAT)(n) triplet repeat in the promoter region of the CNR1 gene is not directly involved in the pathogenesis of schizophrenic disorders. Psychiatr Genet 10:139-151 (C) 2000 Lippincott Williams & Wilkins.

引用

页码：149 / 151

页数：3

共 14 条

[1] CANNABIS AND SCHIZOPHRENIA - A LONGITUDINAL-STUDY OF SWEDISH CONSCRIPTS [J].

ANDREASSON, S ;

ENGSTROM, A ;

ALLEBECK, P ;

RYDBERG, U .

LANCET, 1987, 2 (8574) :1483-1486

[2] Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees [J].

Cao, QH ;

Martinez, M ;

Zhang, J ;

Sanders, AR ;

Badner, JA ;

Cravchik, A ;

Markey, CJ ;

Beshah, E ;

Guroff, JJ ;

Maxwell, ME ;

Kazuba, DM ;

Whiten, R ;

Goldin, LR ;

Gershon, ES ;

Gejman, PV .

GENOMICS, 1997, 43 (01) :1-8

[3] Cannabinoid receptor gene (CNR1): Association with IV drug use [J].

Comings, DE ;

Muhleman, D ;

Gade, R ;

Johnson, P ;

Verde, R ;

Saucier, G ;

MacMurray, J .

MOLECULAR PSYCHIATRY, 1997, 2 (02) :161-168

[4]

DAWSON E, 1995, PSYCHIATR GENET, V5, P50

[5]

DEVANE WA, 1988, MOL PHARMACOL, V34, P605

[6] ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].

DEVANE, WA ;

HANUS, L ;

BREUER, A ;

PERTWEE, RG ;

STEVENSON, LA ;

GRIFFIN, G ;

GIBSON, D ;

MANDELBAUM, A ;

ETINGER, A ;

MECHOULAM, R .

SCIENCE, 1992, 258 (5090) :1946-1949

[7] The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: Implications for schizophrenia [J].

Gray, JA ;

Joseph, MH ;

Hemsley, DR ;

Young, AMJ ;

Warburton, EC ;

Boulenguez, P ;

Grigoryan, GA ;

Peters, SL ;

Rawlins, JNP ;

Taib, CT ;

Yee, BK ;

Cassaday, H ;

Weiner, I ;

Gal, G ;

Gusak, O ;

Joel, D ;

Shadach, E ;

Shalev, U ;

Tarrasch, R ;

Feldon, J .

BEHAVIOURAL BRAIN RESEARCH, 1995, 71 (1-2) :19-31

[8]

HOEHE MR, 1991, NEW BIOL, V3, P880

[9]

IMADE AGT, 1991, ACTA PSYCHIAT SCAND, V83, P134

[10] Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential [J].

Johnson, JP ;

Muhleman, D ;

MacMurray, J ;

Gade, R ;

Verde, R ;

Ask, M ;

Kelley, J ;

Comings, DE .

MOLECULAR PSYCHIATRY, 1997, 2 (02) :169-171

← 1 2 →